News on clinical chemistry systems and applications.
PartoSure includes a noninvasive strip test that detects placental alpha microglobulin in patients and is already being used in 35 countries in Europe, the Middle East, Asia, and Latin America.
The firm said that it expects to log $500 million in revenues from its Alere rapid diagnostics business in the second quarter.
ALK will market Rellergen's Bio-IC lab-on-a-chip technology to more than 190 hospitals in China. The technology uses a blood sample to screen up to 20 different allergens.